Treating Peanut Allergy Through a Patch
DENVER —
Can your peanut-allergic child be treated by simply wearing a patch? That’s what researchers at National Jewish Health are investigating. National Jewish Health, along with four other institutions in the Consortium of Food Allergy Research (CoFAR), are currently testing the safety of a peanut patch.
The peanut patch would seek to desensitize allergic patients by exposing them to increasing amounts of peanut protein, similar to the way allergy shots can desensitize people to pollen. The protein would be delivered through the skin from a patch, like nicotine patches used by people trying to quit tobacco.
“We currently treat food allergy using oral immunotherapy and sublingual immunotherapy or drops under the tongue, but if this patch proves successful, it would likely be a much more convenient treatment option for patients and their families,” said David Fleischer, MD, Pediatric Allergist at National Jewish Health.
Currently patients undergoing immunotherapy need to receive progressively higher doses of their allergenic food protein in their doctor’s office on a regular basis. Researchers hope that the patch could be administered at home and would eliminate the number of office visits.
The peanut patch is currently undergoing a rigorous safety trial. If the safety trial is successful, researchers hope to begin clinical trials to determine if the patch works to desensitize patients allergic to peanut.
“We have a long way to go to determine if this is a viable and safe way to treat peanut allergy,” said Dr. Fleischer. “However, this is potentially a very exciting advance in the treatment of food allergies.”
National Jewish Health is known worldwide for treatment of patients with respiratory, cardiac, immune and related disorders, and for groundbreaking medical research. Founded in 1899 as a nonprofit hospital, National Jewish remains the only facility in the world dedicated exclusively to these disorders. Since 1998, U.S. News & World Report has ranked National Jewish the #1 respiratory hospital in the nation.
National Jewish Health is the leading respiratory hospital in the nation. Founded 125 years ago as a nonprofit hospital, National Jewish Health today is the only facility in the world dedicated exclusively to groundbreaking medical research and treatment of children and adults with respiratory, cardiac, immune and related disorders. Patients and families come to National Jewish Health from around the world to receive cutting-edge, comprehensive, coordinated care. To learn more, visit the media resources page.Media Resources
We have many faculty members, from bench scientists to clinicians, who can speak on almost any aspect of respiratory, immune, cardiac and gastrointestinal disease as well as lung cancer and basic immunology.
Media Contacts
Our team is available to arrange interviews, discuss events and story ideas.
- Adam Dormuth
303.398.1002 office
970.222.5034 mobile
dormutha@njhealth.org - Jessica Berry
303.398.1082 office
303.807.9491 mobile
berryj@njhealth.org